§ 15–601
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health-Gen. § 15-601 (2026)
Title 15. Assistance Programs
Subtitle 6. Prescription Drug Repository Program
§ 15–601LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Board” means the State Board of Pharmacy.
(c)
“Dispense” means to provide:
(1)
A prescription drug or medical supply in accordance with a prescription; or
(2)
An over–the–counter drug or medical supply.
(d)
“Drop–off site” means a pharmacy, other health care facility, or other entity participating in a drug donation or repository program and designated by the Board that:
(1)
Has voluntarily agreed to accept donated prescription drugs, over–the–counter drugs, or medical supplies;
(2)
Is located within the State or in another state; and
(3)
Does not have a final disciplinary order issued against it by a health occupations board.
(e)
“Eligible patient” means an individual who, through self–attestation, is indigent, uninsured, underinsured, or enrolled in a public health benefits program.
(f)
“Program” means the Prescription Drug Repository Program.
(g)
“Repository” means a licensed pharmacy that:
(1)
If the licensed pharmacy is located in the State, does not have a final disciplinary order issued against it by the Board of Pharmacy;
(2)
Has voluntarily agreed to participate in the Program;
(3)
Is located in the State or in another state; and
(4)
Has been approved by the Board to:
(i)
Accept donated prescription drugs, over–the–counter drugs, or medical supplies from a designated drop–off site;
(ii)
Dispense the donated prescription drugs, over–the–counter drugs, or medical supplies to eligible patients; or
(iii)
Dispose of prescription drugs, over–the–counter drugs, or medical supplies not accepted for dispensing to eligible patients.
(h)
“Tamper–evident packaging” means a packaging system that:
(1)
May involve an immediate–container and closure system, secondary–container or carton system, tertiary–container system, or other combination of systems intended to provide a visual indication of package integrity;
(2)
May contain unit–dose or multi–dose contents; and
(3)
Has one or more indicators or barriers to entry that:
(i)
If breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred; and
(ii)
If handled in a reasonable manner during manufacture, distribution, or retail display, is designed to remain intact.